SecSonar.com

Opus Genetics, Inc. (IRD)

Opus Genetics, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Opus Genetics, Inc. (IRD) is a Biotechnology company based in US with a market capitalization of $364.7M. Revenue grew 29.1% year-over-year and free cash flow was negative at -$35.3M. This page tracks IRD's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 18 employees · IPO Jan 19, 2015

Valuation

Valuation & price

$4.26 · as of May 23, 2026 · -25.9% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

23.76

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$5.75$3.37$0.99Jul 25Dec 25Jul 26Jul 7, 25$0.99Jul 9, 25$1.11Jul 11, 25$1.13Jul 15, 25$1.10Jul 17, 25$1.17Jul 21, 25$1.19Jul 23, 25$1.20Jul 25, 25$1.18Jul 29, 25$1.14Jul 31, 25$1.11Aug 4, 25$1.08Aug 6, 25$1.10Aug 11, 25$1.06Aug 13, 25$1.10Aug 15, 25$1.20Aug 19, 25$1.11Aug 21, 25$1.15Aug 25, 25$1.15Aug 27, 25$1.20Aug 29, 25$1.22Sep 3, 25$1.28Sep 5, 25$1.27Sep 9, 25$1.36Sep 11, 25$1.41Sep 16, 25$1.40Sep 18, 25$1.49Sep 22, 25$1.71Sep 24, 25$1.64Sep 26, 25$1.82Sep 30, 25$1.65Oct 2, 25$1.80Oct 6, 25$2.02Oct 8, 25$2.05Oct 10, 25$1.96Oct 14, 25$2.00Oct 16, 25$2.01Oct 21, 25$2.01Oct 23, 25$2.00Oct 27, 25$2.00Oct 29, 25$1.98Oct 31, 25$2.30Nov 4, 25$2.17Nov 6, 25$2.03Nov 10, 25$1.97Nov 12, 25$1.92Nov 14, 25$1.88Nov 18, 25$1.88Nov 20, 25$1.93Nov 25, 25$1.98Nov 28, 25$2.13Dec 2, 25$1.99Dec 4, 25$2.23Dec 8, 25$2.29Dec 10, 25$2.50Dec 12, 25$2.36Dec 16, 25$2.14Dec 18, 25$1.98Dec 22, 25$2.06Dec 24, 25$2.04Dec 29, 25$1.99Jan 2, 26$2.12Jan 6, 26$2.08Jan 8, 26$2.00Jan 12, 26$2.05Jan 14, 26$2.17Jan 16, 26$2.10Jan 21, 26$2.36Jan 23, 26$2.56Jan 27, 26$2.83Jan 29, 26$2.50Feb 2, 26$2.32Feb 4, 26$2.29Feb 9, 26$3.38Feb 11, 26$3.29Feb 13, 26$3.64Feb 18, 26$3.75Feb 20, 26$3.39Feb 24, 26$3.64Feb 26, 26$3.59Mar 2, 26$4.33Mar 4, 26$4.57Mar 6, 26$4.89Mar 10, 26$4.85Mar 12, 26$4.84Mar 17, 26$4.80Mar 19, 26$4.58Mar 23, 26$4.59Mar 25, 26$4.75Mar 27, 26$4.35Mar 31, 26$4.55Apr 2, 26$4.55Apr 7, 26$4.92Apr 9, 26$5.50Apr 13, 26$5.57Apr 15, 26$5.71Apr 17, 26$5.75Apr 22, 26$5.47Apr 24, 26$5.23Apr 28, 26$5.00Apr 30, 26$5.11May 4, 26$5.22May 6, 26$5.26May 8, 26$4.99May 12, 26$5.18May 14, 26$4.97May 18, 26$4.44May 20, 26$4.44May 22, 26$4.26May 28, 26$4.20Jun 1, 26$4.12Jun 3, 26$4.20Jun 5, 26$4.03Jun 9, 26$4.08Jun 11, 26$3.91Jun 15, 26$3.92Jun 17, 26$4.06Jun 22, 26$4.08Jun 24, 26$3.71Jun 26, 26$4.00Jul 2, 26$4.23
$0.9952-week range$5.75
Loading valuation history…

Fundamentals

Key fundamentals

$364.7M

Market cap

29.1%

Revenue growth (YoY)

100.0%

Gross margin

-$35.3M

Free cash flow (USD)

-$45.1M

Net debt

Net cash position

2229.1%

Share dilution

1/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2019 → 2025

FY 2019$0.00FY 2020$0.00FY 2021$589.0KFY 2022$39.9MFY 2023$19.0MFY 2024$11.0MFY 2025$14.2M
$0$14.2M

Free cash flow by year

2019 → 2025

FY 2019$-3.6MFY 2020$-6.8MFY 2021$-19.4MFY 2022$14.3MFY 2023$-1.1MFY 2024$-25.6MFY 2025$-35.3M
-$3.6M-$35.3M

Gross margin by year

2021 → 2025

FY 2021100.0%FY 2022100.0%FY 2023100.0%FY 2024100.0%FY 2025100.0%
100.0%100.0%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last reported: May 21, 2026 (EPS $-0.19)

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventR&D Science Forum AnnouncementJun 16, 2026Filing
  • 8-K eventR&D Science ForumJun 16, 2026Filing
  • FinancingSecurities RegistrationJun 5, 2026Filing
  • 8-K eventEarnings ReleaseMay 12, 2026Filing
  • Quarterly report10-Q FiledMay 12, 2026Filing
  • 8-K eventDebt FinancingApr 24, 2026Filing
  • 8-K eventAnnual Meeting ResultsApr 22, 2026Filing
  • FinancingSecurities RegistrationApr 21, 2026Filing
  • 8-K eventNote Purchase AgreementApr 7, 2026Filing
  • 8-K eventChange in Control AgreementApr 7, 2026Filing

Questions

Frequently asked questions

What is Opus Genetics, Inc.'s market cap?

Opus Genetics, Inc. (IRD) has a market capitalization of $364.7M.

What is IRD's P/E ratio?

A meaningful P/E ratio is not available for IRD — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is IRD's price-to-book (P/B) ratio?

IRD trades at 23.76 times book value per share.

When did Opus Genetics, Inc. last report earnings?

IRD last reported earnings on May 21, 2026; the next date is not yet scheduled.

Are insiders buying IRD stock?

SEC Form 4 filings show no open-market insider buys at Opus Genetics, Inc. in the last 90 days (0 sells).

Same arena

Related companies in Biotechnology

PBYI

Puma Biotechnology, Inc.

$364.7M

RGNX

REGENXBIO Inc.

$365.2M

PALI

Palisade Bio, Inc.

$366.3M

KROS

Keros Therapeutics, Inc.

$361.9M

CCCC

C4 Therapeutics, Inc.

$367.8M

PTN

Palatin Technologies, Inc.

$368M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.